What is Inference?
Inference Inc. operates as a specialized independent statistical center, providing essential biometrics support for the drug development lifecycle. The company offers a comprehensive suite of services, including biostatistics, statistical programming, pharmacokinetics, data management, and medical writing. By acting as a bridge between complex clinical data and regulatory requirements, Inference Inc. ensures the integrity and accuracy of clinical trials. Their market position is defined by a commitment to unbiased analysis, which serves as a cornerstone for biotech and pharmaceutical firms navigating the rigorous demands of regulatory submissions and high-stakes decision-making processes.
How much funding has Inference raised?
Inference has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Inference
PPP
Public-Private Partnership
What's next for Inference?
With this recent influx of capital, Inference Inc. is poised to scale its operational capacity to meet the growing demand for high-fidelity clinical data monitoring. The strategic focus will likely shift toward enhancing their proprietary statistical programming frameworks and expanding their medical writing capabilities to support more complex, global clinical trial portfolios. As the healthcare industry continues to prioritize data-driven regulatory pathways, Inference Inc. is strategically aligned to capture further market share by providing the technical rigor necessary for successful drug commercialization and long-term therapeutic development.
See full Inference company page
